Shares declined 4 percent following the companys Q2FY25 results, which led JP Morgan to reaffirm its Underweight stance citing an EBITDA shortfall driven by unfavorable inventory impact and increased other expenses. The firm also said, however, that it does not anticipate significant adjustments to consensus forecasts, as the inventory impact may reverse in the second half of FY25.
MARKET VIEW
OUTLOOK
SECTORS
STRATEGY
VIEW
PERSONAL FINANCE
INSURANCE
INVEST
MUTUAL FUND
GENERAL
FEEDBACK